{"organizations": [], "uuid": "fd7b758649fe0d8e82bc4748af8c330e1cf25b87", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180511.html", "section_title": "Archive News &amp; Video for Friday, 11 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-scythian-biosciences-announces-bin/brief-scythian-biosciences-announces-binding-agreement-for-argentinian-acquisition-of-abp-idUSASC0A1SF", "country": "US", "domain_rank": 408, "title": "BRIEF-Scythian Biosciences Announces Binding Agreement For Argentinian Acquisition Of Abp", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.224, "site_type": "news", "published": "2018-05-11T20:35:00.000+03:00", "replies_count": 0, "uuid": "fd7b758649fe0d8e82bc4748af8c330e1cf25b87"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-scythian-biosciences-announces-bin/brief-scythian-biosciences-announces-binding-agreement-for-argentinian-acquisition-of-abp-idUSASC0A1SF", "ord_in_thread": 0, "title": "BRIEF-Scythian Biosciences Announces Binding Agreement For Argentinian Acquisition Of Abp", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "argentinian acquisition of abp scythian biosciences corp", "sentiment": "negative"}, {"name": "scythian biosciences corp", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "abp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Scythian Biosciences Corp:\n* SCYTHIAN BIOSCIENCES ANNOUNCES BINDING AGREEMENT FOR ARGENTINIAN ACQUISITION OF ABP\n* SCYTHIAN BIOSCIENCES CORP - SCYTHIAN TO ACQUIRE ALL OF ISSUED AND OUTSTANDING COMMON SHARES OF MMJ BY WAY OF A THREE-CORNERED AMALGAMATION\n* SCYTHIAN BIOSCIENCES CORP - IN CONSIDERATION, SCYTHIAN TO ISSUE AN AGGREGATE OF 6.2 COMMON SHARES OF COMPANY TO SHAREHOLDERS OF MMJ\n* SCYTHIAN BIOSCIENCES CORP - THE TRANSACTION WILL NOT CONSTITUTE A “REVERSE-TAKEOVER” OF SCYTHIAN UNDER POLICIES OF TSXV Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-11T20:35:00.000+03:00", "crawled": "2018-05-12T17:21:16.014+03:00", "highlightTitle": ""}